Lymphoma Treatment Options

Explore treatment options for lymphoma available in China with CAR T cell therapies.

Why going to China for cancer treatment?

Lymphoma is a cancer that develops in the lymphatic system, impacting lymphocytes, a type of white blood cell crucial for the body’s immune response. This condition results in the abnormal growth of these cells, forming tumors in lymph nodes or other lymphoid tissues, affecting the body’s ability to fight infections effectively.

Types of lymphoma

There are two main types of lymphoma: Hodgkin and non-Hodgkin lymphoma. Within these, there are many subtypes.

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma, which is the most common type, typically develops from B and T lymphocytes in the lymph nodes or tissues throughout the body. Tumor growth in non-Hodgkin lymphoma may not affect every lymph node, often skipping some and growing on others.

According to the National Cancer Institute (NCI), non-Hodgkin lymphoma accounts for 4.1% of all cancers in the United States, and a person’s lifetime risk of developing it is about 2.1%.

Hodgkin lymphoma

Doctors can identify Hodgkin lymphoma due to the presence of Reed-Sternberg cells, which are abnormally large B lymphocytes. In people with Hodgkin lymphoma, the cancer usually moves from one lymph node to an adjacent one.

The NCI estimate that Hodgkin lymphoma accounts for 0.5% of all cancers and approximately 0.2% of people in the U.S. will receive a diagnosis in their lifetime.

Contact a specialist

CAR T Cell Therapy in Lymphoma Treatment

0 %+
Response Rate
0 %
Complete Rate
0 +
Patients Treated
0 %
Less in Cost